-
公开(公告)号：US08912304B2
公开(公告)日：2014-12-16
申请号：US12600596
申请日：2008-05-16
IPC分类号： C08G63/02 , C08G63/668 , A61L27/54 , A61L27/52 , A61L27/58 , A61L27/38 , A61L27/16 , C08G63/21 , C08F283/00
CPC分类号： C08G63/668 , A61L27/16 , A61L27/38 , A61L27/52 , A61L27/54 , A61L27/58 , A61L2300/604 , C08G63/21 , C08L33/02
摘要： The present invention provides inventive polyol-based polymers, materials, pharmaceutical compositions, and methods of making and using the inventive polymers and materials. In certain aspects of the invention, an inventive polymer corresponds to a polymer depicted below. Exemplary inventive polymers includes those prepared using polyol units (e.g., xylitol, mannitol, sorbitol, or maltitol) condensed with polycarboxylic acid units (e.g., citric acid, glutaric acid, or sebacic acid). The inventive polymers may be further derivatized or modified. For example, the polymer may be made photocrosslinkable by adding methacrylate moieties to the polymer.
摘要翻译： 本发明提供本发明的多元醇基聚合物，材料，药物组合物以及制备和使用本发明的聚合物和材料的方法。 在本发明的某些方面，本发明的聚合物对应于下面描述的聚合物。 示例性的本发明聚合物包括使用与多元羧酸单元（例如柠檬酸，戊二酸或癸二酸）缩合的多元醇单元（例如木糖醇，甘露糖醇，山梨糖醇或麦芽糖醇）制备的那些聚合物。 本发明的聚合物可进一步衍生或修饰。 例如，可以通过向聚合物中加入甲基丙烯酸酯部分使聚合物可光交联。
-
82.发明申请公开(公告)号：US20130280334A1
公开(公告)日：2013-10-24
申请号：US13825486
申请日：2011-09-23
申请人： Jeffrey M. Karp , Praveen Kumar Vemula , Nathaniel R. Campbell , Abdullah M. Syed , Sufeng Zhang , Omid C. Farokhzad , Robert S. Langer
发明人： Jeffrey M. Karp , Praveen Kumar Vemula , Nathaniel R. Campbell , Abdullah M. Syed , Sufeng Zhang , Omid C. Farokhzad , Robert S. Langer
IPC分类号： A61K47/14
CPC分类号： A61K47/22 , A61K9/0019 , A61K9/06 , A61K9/1075 , A61K31/166 , A61K31/405 , A61K31/4188 , A61K31/4745 , A61K31/573 , A61K31/58 , A61K31/713 , A61K38/28 , A61K47/14 , A61K47/26 , A61K47/28
摘要： Self-assembled gel compositions including a gelator, e.g., an enzyme-cleavable gelator, e.g., having a molecular weight of 2500 or less, are described. The self-assembled gel compositions can encapsulate one or more agents. Methods of making the self-assembled gel compositions, and methods of drug delivery using the self-assembled gel compositions are also described.
摘要翻译： 描述了包含胶凝剂，例如分子量为2500以下的可酶切割凝胶剂的自组装凝胶组合物。 自组装凝胶组合物可以包封一种或多种试剂。 还描述了使用自组装凝胶组合物制备自组装凝胶组合物的方法和药物递送方法。
-
公开(公告)号：US08562966B2
公开(公告)日：2013-10-22
申请号：US13312224
申请日：2011-12-06
CPC分类号： C12N15/87 , A61K9/5138 , A61K47/34 , C08G63/6856 , C08G73/02 , C08L79/02
摘要： Poly(beta-amino esters) are end-modified to form materials useful in the medical as well as non-medical field. An amine-terminated poly(beta-amino ester) is reacted with an electrophile, or an acrylate-terminated poly(beta-amino ester) is reacted with a nucleophile. The inventive end-modified polymers may be used in any field where polymers have been found useful including the drug delivery arts. The end-modified polymers are particularly useful in delivery nucleic acids such as DNA or RNA. The invention also provides compositions including the inventive end-modified polymers, methods of preparing the inventive polymers, and method of using the inventive polymers.
摘要翻译： 聚（β-氨基酯）被末端修饰以形成用于医疗和非医学领域的材料。 使胺封端的聚（β-氨基酯）与亲电子试剂或丙烯酸酯封端的聚（β-氨基酯）与亲核试剂反应。 本发明的末端改性聚合物可用于已经发现聚合物有用的任何领域，包括药物递送领域。 末端修饰的聚合物特别可用于递送核酸如DNA或RNA。 本发明还提供包含本发明的端基改性聚合物，制备本发明聚合物的方法和使用本发明聚合物的方法的组合物。
-
公开(公告)号：US08367113B2
公开(公告)日：2013-02-05
申请号：US11803843
申请日：2007-05-15
CPC分类号： C08G63/912 , A61K9/5153 , A61K47/549 , A61K47/593 , A61K47/60 , A61K47/6935 , A61K47/6937 , A61K49/00 , A61K51/1244 , B82Y5/00 , Y10S977/773 , Y10S977/906 , Y10S977/915 , Y10T428/2982
摘要： The present invention generally relates to polymers and macromolecules, in particular, to block polymers useful in particles such as nanoparticles. One aspect of the invention is directed to a method of developing nanoparticles with desired properties. In one set of embodiments, the method includes producing libraries of nanoparticles having highly controlled properties, which can be formed by mixing together two or more macromolecules in different ratios. One or more of the macromolecules may be a polymeric conjugate of a moiety to a biocompatible polymer. In some cases, the nanoparticle may contain a drug. The moiety, in some embodiments, may have a molecular weight greater than about 1000 Da; for example, the moiety may include a polypeptide or a polynucleotide, such as an aptamer. The moiety may also be a targeting moiety, an imaging moiety, a chelating moiety, a charged moiety, or a therapeutic moiety. Another aspect of the invention is directed to systems and methods of producing such polymeric conjugates. In some embodiments, a solution containing a polymer is contacted with a liquid, such as an immiscible liquid, to form nanoparticles containing the polymeric conjugate. Other aspects of the invention are directed to methods using such libraries, methods of using or administering such polymeric conjugates, methods of promoting the use of such polymeric conjugates, kits involving such polymeric conjugates, or the like.
摘要翻译： 本发明一般涉及聚合物和大分子，特别是阻止可用于颗粒如纳米颗粒的聚合物。 本发明的一个方面涉及一种开发具有所需性质的纳米颗粒的方法。 在一组实施方案中，该方法包括制备具有高度控制性质的纳米颗粒的文库，其可通过将两种或多种不同比例的大分子混合在一起形成。 一个或多个大分子可以是部分与生物相容性聚合物的聚合物缀合物。 在一些情况下，纳米颗粒可以含有药物。 在一些实施方案中，该部分可具有大于约1000Da的分子量; 例如，该部分可以包括多肽或多核苷酸，例如适体。 该部分还可以是靶向部分，成像部分，螯合部分，带电部分或治疗部分。 本发明的另一方面涉及制备这种聚合物缀合物的系统和方法。 在一些实施方案中，将含有聚合物的溶液与诸如不混溶液体的液体接触以形成含有聚合物缀合物的纳米颗粒。 本发明的其它方面涉及使用这种文库的方法，使用或施用这种聚合物缀合物的方法，促进使用这种聚合物缀合物的方法，涉及这种聚合物缀合物的试剂盒等。
-
公开(公告)号：US08308707B2
公开(公告)日：2012-11-13
申请号：US13012426
申请日：2011-01-24
申请人： John T. Santini, Jr. , Michael J. Cima , Robert S. Langer , Dennis Ausiello , Norman F. Sheppard, Jr. , Stephen J. Herman
发明人： John T. Santini, Jr. , Michael J. Cima , Robert S. Langer , Dennis Ausiello , Norman F. Sheppard, Jr. , Stephen J. Herman
IPC分类号： A61M31/00
CPC分类号： A61K9/0051 , A61F9/0017 , A61K9/0009 , A61K9/0048 , A61K9/0097 , H01L24/96 , H01L2924/01004 , H01L2924/01005 , H01L2924/01006 , H01L2924/01011 , H01L2924/01013 , H01L2924/01015 , H01L2924/0102 , H01L2924/01027 , H01L2924/01033 , H01L2924/01074 , H01L2924/01075 , H01L2924/01079 , H01L2924/014 , H01L2924/12041 , H01L2924/12042 , H01L2924/12043 , H01L2924/14 , H01L2924/1461 , H01L2924/19041 , H01L2924/19043 , H01L2924/00
摘要： Methods and systems are provided for delivering drug to the eye. The method and system may include implanting into the eye a device which comprises two or more discrete reservoirs, each reservoir containing a drug; and directing focused light to the implanted device to open a first one of the reservoirs and thereby permit the drug to diffuse from the first reservoir to the patient's eye.
摘要翻译： 提供了将药物输送到眼睛的方法和系统。 该方法和系统可以包括将包括两个或更多个离散储器的装置植入眼中，每个储存器包含药物; 以及将聚焦光引导到所述植入装置以打开所述储存器中的第一个，从而允许所述药物从所述第一储存器扩散到所述患者的眼睛。
-
公开(公告)号：US20120213708A1
公开(公告)日：2012-08-23
申请号：US13400382
申请日：2012-02-20
CPC分类号： A61K9/1641 , A61K9/0019 , A61K31/573 , A61K35/39 , A61K45/06 , A61L27/3804 , A61L27/48 , A61L27/52 , A61L27/54 , A61L2300/41 , A61L2300/622 , A61L2300/64 , C12N5/0676 , C12N2502/1157 , C12N2533/40 , C12N2533/74 , G01N33/5088 , A61K2300/00 , C08L5/04 , C08L5/08
摘要： A composition containing biocompatible hydrogel encapsulating mammalian cells and anti-inflammatory drugs is disclosed. The encapsulated cells have reduced fibrotic overgrowth after implantation in a subject. The compositions contain a biocompatible hydrogel having encapsulated therein mammalian cells and anti-inflammatory drugs or polymeric particles loaded with anti-inflammatory drugs. The anti-inflammatory drugs are released from the composition after transplantation in an amount effective to inhibit fibrosis of the composition for at least ten days. Methods for identifying and selecting suitable anti-inflammatory drug-loaded particles to prevent fibrosis of encapsulated cells are also described. Methods of treating a disease in a subject are also disclosed that involve administering a therapeutically effective amount of the disclosed encapsulated cells to the subject.
摘要翻译： 公开了含有包封哺乳动物细胞和抗炎药物的生物相容性水凝胶的组合物。 包被的细胞在植入受试者后具有减少的纤维化过度生长。 所述组合物包含具有包封哺乳动物细胞和抗炎药物或装有抗炎药物的聚合物颗粒的生物相容性水凝胶。 抗炎药从移植后的组合物中以有效抑制组合物纤维化至少十天的量释放。 还描述了鉴定和选择合适的抗炎药物负载颗粒以防止包封细胞纤维化的方法。 还公开了治疗受试者疾病的方法，其涉及向受试者施用治疗有效量的所公开的封闭细胞。
-
公开(公告)号：US20120149630A1
公开(公告)日：2012-06-14
申请号：US13312224
申请日：2011-12-06
IPC分类号： A61K38/02 , A61K31/7088 , C08G63/91 , A61K47/34 , B82Y5/00
CPC分类号： C12N15/87 , A61K9/5138 , A61K47/34 , C08G63/6856 , C08G73/02 , C08L79/02
摘要： Poly(beta-amino esters) are end-modified to form materials useful in the medical as well as non-medical field. An amine-terminated poly(beta-amino ester) is reacted with an electrophile, or an acrylate-terminated poly(beta-amino ester) is reacted with a nucleophile. The inventive end-modified polymers may be used in any field where polymers have been found useful including the drug delivery arts. The end-modified polymers are particularly useful in delivery nucleic acids such as DNA or RNA. The invention also provides compositions including the inventive end-modified polymers, methods of preparing the inventive polymers, and method of using the inventive polymers.
摘要翻译： 聚（β-氨基酯）被末端修饰以形成用于医疗和非医学领域的材料。 使胺封端的聚（β-氨基酯）与亲电子试剂或丙烯酸酯封端的聚（β-氨基酯）与亲核试剂反应。 本发明的末端改性聚合物可用于已经发现聚合物有用的任何领域，包括药物递送领域。 末端修饰的聚合物特别可用于递送核酸如DNA或RNA。 本发明还提供包含本发明的端基改性聚合物，制备本发明聚合物的方法和使用本发明聚合物的方法的组合物。
-
公开(公告)号：US20120009222A1
公开(公告)日：2012-01-12
申请号：US13126260
申请日：2009-10-27
IPC分类号： A61K31/7088 , A61P37/02 , B82Y5/00
CPC分类号： A61K39/39 , A61K31/132 , A61K47/6911 , A61K47/6921 , A61K2039/55561 , A61K2039/55572 , C12N2760/16011
摘要： The present invention provides lipidoids that can be used to modulate the immune response in a subject. Lipidoids are prepared by the conjugate addition of an amine to an acrylate to acrylamide. The lipidoids form complexes or particles with an immunostimulatory polynucleotide, which are then administerd to a subject. Such compositions have been found to stimulate the production of cytokines and increase both humoral and cell-mediate immune response. The invention also provides pharmaceuti-cal compositions thereof and methods for using the same.
摘要翻译： 本发明提供可用于调节受试者的免疫应答的类脂质。 通过将丙烯酸丁酯偶联加成丙烯酰胺制备脂质体。 脂类与免疫刺激多核苷酸形成复合物或颗粒，然后将其施用于受试者。 已经发现这些组合物刺激细胞因子的产生并增加体液和细胞中介免疫应答。 本发明还提供其药物组合物及其使用方法。
-
公开(公告)号：US20110280912A1
公开(公告)日：2011-11-17
申请号：US12969558
申请日：2010-12-15
申请人： Robert S. Langer , Ana Jaklenec , Daniel Alan Heller , Daniel Griffith Anderson , Michael S. Strano
发明人： Robert S. Langer , Ana Jaklenec , Daniel Alan Heller , Daniel Griffith Anderson , Michael S. Strano
CPC分类号： C08J5/005 , B82Y30/00 , C08J2379/00
摘要： This invention relates generally to composites comprising a plurality of nanostructures, and methods of making the same. In some embodiments, the composites further comprise a polymer. In some embodiments, the composites may have desirable properties such as, for example, biodegradability, biocompatibility, and/or high tensile strength. In one embodiment, the plurality of nanostructures comprises carbon nanotubes, and the polymer comprises a poly(beta-amino ester). Various methods are provided for preparing the composites. For example, the polymer and the plurality of nanostructures may, in some embodiments, be combined in a layer-by-layer process to form the composite. High throughput methods for preparing composites having different compositions also are provided for screening composites for desirable properties.
摘要翻译： 本发明一般涉及包含多个纳米结构的复合材料及其制备方法。 在一些实施方案中，复合材料还包含聚合物。 在一些实施方案中，复合材料可具有期望的性质，例如生物降解性，生物相容性和/或高拉伸强度。 在一个实施方案中，多个纳米结构包含碳纳米管，并且聚合物包含聚（β-氨基酯）。 提供了各种制备复合材料的方法。 例如，在一些实施方案中，聚合物和多个纳米结构可以以逐层方法组合以形成复合材料。 还提供了用于制备具有不同组成的复合材料的高通量方法用于筛选复合材料以获得所需性能。
-
公开(公告)号：US20110163469A1
公开(公告)日：2011-07-07
申请号：US12094098
申请日：2006-12-13
IPC分类号： B29B9/00
CPC分类号： A61K9/1647 , A61K9/1694
摘要： The high-throughput fabrication of microparticles based on the double emulsion/solvent evaporation technique for screening and optimizing microparticle formulations for particular characteristics allows for the preparation of multiple microparticle formulations in parallel. The system involves the formation of an emulsion containing aqueous bubbles with the payload in an organic phase containing the polymer or polymer blend being used for the microparticles. This first emulsion is then transferred to a larger aqueous phase, and a second waterin-oil-in water emulsion is formed. The organic solvent is then removed, and the resulting particles are optionally washed and/or freeze dried. The resulting microparticles are similar or better than microparticles prepared using the traditional one formulation at a time approach. The high-throughput fabrication of microparticles is particularly useful in optimizing microparticles formulations for drug delivery.
摘要翻译： 基于用于筛选和优化微粒制剂以获得特定特征的基于双重乳液/溶剂蒸发技术的微粒的高通量制造允许并行制备多个微粒制剂。 该系统包括在含有用于微粒的聚合物或聚合物共混物的有机相中形成含有水泡的含水气泡。 然后将该第一乳液转移到较大的水相中，并形成第二水包油包水乳液。 然后除去有机溶剂，任选地将所得颗粒洗涤和/或冷冻干燥。 所得到的微粒类似于或优于使用传统的一种制剂在一段时间内制备的微粒。 微粒的高通量制造特别可用于优化用于药物递送的微粒制剂。
-
-
-
-
-
-
-
-
-
搜索结果
351 条记录 (耗时 0.056 秒)
